| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.37 | -0.02 (-0.84%) | 1.73 - 2.68 | 10.1 thousand (Below Avg) |
Market data as of 11:00AM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 2.39 |
|---|---|
| Previous Close | 2.39 |
| Day's Range | 2.36 - 2.39 |
| Market Cap | 45.6M |
| Avg Volume (10 Day) | 116.0K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.33 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for DRAD
| DRAD | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -6.57% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 0.94 |
| Company | Last | Change |
|---|---|---|
| IRIDEX Corp | 5.50 | +2.61% |
| Uroplasty Inc | 2.13 | -0.93% |
| Vision Sciences Inc | 0.97 | 0.00% |
| Edap Tms SA | 2.88 | -0.35% |
| BSD Medical Corp | 1.30 | +0.78% |
Data is delayed by at least 15 min.